Activity
-
Looking forward to a lively discussion tomorrow!
Looking forward to a lively discussion tomorrow!
Shared by K. Nicole Clouse
-
It was a privilege to represent the U.S. Department of Homeland Security at the "Artificial Intelligence and Intellectual Property Law Conference" at…
It was a privilege to represent the U.S. Department of Homeland Security at the "Artificial Intelligence and Intellectual Property Law Conference" at…
Liked by K. Nicole Clouse
Experience
Education
Licenses & Certifications
Publications
-
Claims Need Only Inform a Skilled Artisan of the Metes and Bounds with Reasonable Certainty
IP Update -- McDermott Will & Emery
Case note: Nevro Corp. v. Boston Sci. Corp., Case Nos. 18-2220; -2349 (Fed. Cir. Apr. 9, 2020) (Moore, J.).
-
Real-World Evidence of Clinical Failure Cuts Against Reasonable Expectation of Success
IP Update -- McDermott Will & Emery
Case note: OSI Pharm., LLC v. Apotex Inc., 939 F.3d 1375 (Fed. Cir. 2019).
-
"100%" Does Not Necessarily Mean "All"
IP Update -- McDermott Will & Emery
Case note: E.I. DuPont de Nemours & Co. v. Unifrax I LLC, 921 F.3d 1060 (Fed. Cir. 2019).
-
Post-Priority References Can Be Used in Context of Obviousness Analysis
IP Update -- McDermott Will & Emery
Case note: Yeda Research & Dev. Co. v. Mylan Pharm. Inc., 906 F.3d 1031 (Fed. Cir. 2018) and In re Copaxone Consol. Cases, 906 F.3d 1013 (Fed. Cir. 2018).
-
Prediction: "Plain and Ordinary Meaning" Is Not Particularly Plain or Ordinary
IP Update -- McDermott Will & Emery
Wis. Alumni Research Found. v. Apple Inc., 905 F.3d 1341 (Fed. Cir. 2018).
-
Judicial Economy Considerations Can Determine Whether and When a Claim Is Heard
ANDA Update -- McDermott Will & Emery
Case note: Fresenius Kabi USA, LLC v. Fera Pharm., LLC, Case No. 15-3654 (D.N.J., May 19, 2017) (McNulty, J).
-
No Right to a Jury for Award of Attorney's Fees
IP Update -- McDermott Will & Emery
Case note: AIA Am., Inc. v. Avid Radiopharmaceuticals, 866 F.3d 1369 (Fed. Cir. 2017).
-
General “Desire” to Improve Can Provide Sufficient Rationale to Combine References
IP Update -- McDermott Will & Emery
Case note: In re Ethicon, Inc., 844 F.3d 1344 (Fed. Cir. 2017).
-
Infringement of Method Claim Still Requires Performance of Every Claimed Step
IP Update -- McDermott Will & Emery
Case note: Medgraph, Inc. v. Medtronic, Inc., 843 F.3d 942 (Fed. Cir. 2016).
-
Prosecution History Disclaimer of Claim Scope Must Be “Clear and Unambiguous” in View of the Prosecution History as a Whole
IP Update -- McDermott Will & Emery
Case note: Mass. Inst. of Tech. v. Shire Pharm., Inc., 839 F.3d 1111 (Fed. Cir. 2016).
-
Claim Construction Disputes Should Be Affirmatively and Formally Raised
IP Update -- McDermott Will & Emery
Case note: LifeNet Health v. LifeCell Corp., 837 F.3d 1316 (Fed. Cir. 2016).
-
Once Again, Genetic Diagnostic Claims Found Unpatentable Under § 101
IP Update -- McDermott Will & Emery
Case note: Genetic Tech. Ltd. v. Merial LLC, 818 F.3d 1369 (Fed. Cir. 2016).
-
Propriety of a Certificate of Correction Requires Assessment of the Teachings of the Specification as a Whole
IP Update -- McDermott Will & Emery
Case note: Cubist Pharms., Inc. v. Hospira, Inc., 805 F.3d 1112 (Fed. Cir. 2015).
-
A Substantially Pure Isomer Is Obvious When the Completely Pure Isomer Is Known In The Art
IP Update -- McDermott Will & Emery
Case note: Spectrum Pharm., Inc. v. Sandoz Inc., 802 F.3d 1326 (Fed. Cir. 2015).
-
Supplier to ANDA Filer Is Not Liable for Induced Infringement Until After ANDA Approval
IP Update -- McDermott Will & Emery
Case note: Shire LLC v. Amneal Pharms., LLC, 802 F.3d 1301 (Fed. Cir. 2015).
-
No Induced Infringement Where Off-Label Use of a Drug is Not "Inevitable"
IP Update -- McDermott Will & Emery
Case note: Takeda Pharm. U.S.A., Inc. v. West-Ward Pharm. Corp., 785 F.3d 625 (Fed. Cir. 2015).
-
The "Totality of the Specification" Can Override a District Court's Factual Findings
IP Update -- McDermott Will & Emery
Case note: Enzo Biochem Inc. v. Applera Corp., 780 F.3d 1149 (Fed. Cir. 2015).
-
PTAB Rejects Attempts to Expand the Scope of CBM Review
IP Update -- McDermott Will & Emery
Case note: Par Pharm., Inc. v. Jazz Pharm., Inc., Case Nos. CBM2014-00149, -0150, -0151 and -0153 (PTAB, Jan. 13, 2015) (Murphy, APJ).
-
PTAB Applies Balancing Test in Deciding Motions to Seal Evidence
IP Update -- McDermott Will & Emery
Case note: Search Am., Inc. v. TransUnion Intelligence, LLC, Case Nos. CBM2013-00037; -00038 (PTAB, Oct. 2, 2014) (Giannetti, APJ).
-
PTAB Clarifies Permissible Use of Documents and Evidence
IP Update -- McDermott Will & Emery
Case note: Medtronic, Inc. v. Endotach, LLC, Case No. IPR2014-00100 (PTAB, Aug. 28, 2014) (Fitzpatrick, APJ) and TriVascular, Inc. v. Samuels, Case No. IPR2013-00493 (PTAB, Sept. 2, 2014) (Kamholz, APJ).
-
Movants Face a High Bar to Succeed on Motions to Amend
IP Update -- McDermott Will & Emery
Case note: Intelligent Bio-Systems, Inc. v. Illumina Cambridge Ltd., IPR2013-00128 (PTAB, July 25, 2014) (Lebovitz, APJ.).
-
Genus Claims Require Disclosure of “Representative Species Encompassing the Breadth of the Genus”
IP Update -- McDermott Will & Emery
Case note: AbbVie Deutschland GmbH & Co., KG v. Janssen Biotech, Inc., 759 F.3d 1285 (Fed. Cir. 2014).
-
Statutory Right to Appeal Does Not Bypass Article III Standing Requirements
IP Update -- McDermott Will & Emery
Case note: Consumer Watchdog v. Wisconsin Alumni Research Foundation, 753 F.3d 1258 (Fed. Cir. 2014).
-
Statutory Right to Appeal Does Not Bypass Article III Standing Requirements
IP Update -- McDermott Will & Emery
Case note: Consumer Watchdog v. Wisconsin Alumni Research Foundation, 753 F.3d 1258 (Fed. Cir. 2014).
-
Disclosure of a Single Embodiment Can Provide Sufficient Written Description
IP Update -- McDermott Will & Emery
Case note: Tobinick v. Olmarker, 753 F.3d 1220 (Fed. Cir. 2014).
-
Evidence in Support of Petition for Venue Transfer Must Be Sufficiently Specific
IP Update -- McDermott Will & Emery
Case note: In re Apple Inc., 743 F.3d 1377 (Fed. Cir. 2014) and In re Barnes & Noble, 743 F.3d 1381 (Fed. Cir. 2014).
-
A Generic Disclosure Does Not Support Claims to Individual Species
IP Update -- McDermott Will & Emery
Case note: Novozymes A/S v. DuPont Nutrition Biosciences APS, 723 F.3d 1336 (Fed. Cir. 2013).
-
Patent Claims Must Recite Significantly More than a Law of Nature
Intellectual Property Today
Case note: Mayo Collaborative Services v. Prometheus Laboratories, Inc., 566 U.S. 10 (2012).
Other authors -
-
Claim Term “a” Does Not Necessarily Include Singular or Plural
IP Frontline
Case note: Eliyahou Harari et al. v. Roger Lee, et al., 656 F.3d 1331 (Fed. Cir. 2011).
Other authors -
-
A Ran-independent pathway for export of spliced mRNA
Nature Cell Biology
Organizations
-
Intellectual Property Owners Association (IPO)
Artificial Intelligence, Data & New Emerging Technologies Committee
- Present -
Intellectual Property Owners Association (IPO)
U.S. Post-Grant Patent Office Practice Committee
- -
Women in Bio -- Greater Boston Chapter
Vice Chair (2015); Programming Chair (2014)
-http://www.womeninbio.org/wib-chapters/greater-boston/
More activity by K. Nicole
-
It was such an honor to speak about "What #AI Can Do Today, and Where AI Is Headed" at the Artificial Intelligence and Intellectual Property Law…
It was such an honor to speak about "What #AI Can Do Today, and Where AI Is Headed" at the Artificial Intelligence and Intellectual Property Law…
Shared by K. Nicole Clouse
-
Great to be back in the US meeting old friends and making new connections. Looking forward to discussing the numerous and varied ways patents can now…
Great to be back in the US meeting old friends and making new connections. Looking forward to discussing the numerous and varied ways patents can now…
Liked by K. Nicole Clouse
-
Our #UnapologeticallyScientific Mindset Award celebrates those who challenge the status quo, embrace bold solutions, and push the boundaries of…
Our #UnapologeticallyScientific Mindset Award celebrates those who challenge the status quo, embrace bold solutions, and push the boundaries of…
Liked by K. Nicole Clouse
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More